MARKET COMPOSITE
ACB - Aurora Cannabis Inc8:00:00 PM 3/28/2024
Price
$4.75
+ 0.54 (12.83%)
Aurora Cannabis Inc. produces and distributes medical cannabis products worldwide. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, including facility engineering and design, cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories, including valves, screens, etc.; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and ROAR Sports. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.
Stock Chart

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 

Finra

Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.

Stock news

    In this article, we discuss 10 cannabis ETFs to explore. If you want to skip our detailed discussion on the cannabis industry, head directly to Navigating Regulatory Changes: 5 Cannabis ETFs To Explore. In September last year, shares of marijuana firms fell after rising initially, following a US Senate Committee’s vote to pass a bill […]

    Aurora Cannabis could earn a profit in 2026, if it lives that long.

    Cannabis-related stocks such as Tilray Brands (TLRY), Canopy Growth (CGC), Aurora Cannabis (ACB) jumped on news out of Canada and Germany. In Canada, a government group brought together to study the impacts of the legalization legislation recommends the country reduce the excise taxes producers have to pay. Meanwhile, Germany has decriminalized cannabis for personal use. Yahoo Finance's Josh Lipton and Julie Hyman discuss the moves in the video above. For more expert insight and the latest marke...

    Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) – The Canadian based leading global medical cannabis company has received Good Manufacturing Practice (GMP) certification from Australia's Therapeutic Goods Administration (TGA) for its Canadian production facilities, River and Ridge. The TGA is responsible for regulating the supply, import, export, manufacturing and advertising of therapeutic goods in Australia. Obtaining TGA's GMP certification enables the company to deliver top-tier cannabis produ

    Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) – The Canadian based leading global medical cannabis company, together with subsidiary company, MedReleaf Australia, have announced today the availability of medical cannabis pastilles for doctors to prescribe to patients in Australia. The novel product is produced by Aurora and distributed by MedReleaf Australia, a leading distributor of medical cannabis products with the number two position in the Australian market.

    Aurora Cannabis Inc. ("Aurora" or the "Company") (NASDAQ: ACB) (TSX: ACB), the Canada-based leading global medical cannabis company, today announced that it has repaid an aggregate of approximately $7.2 million (US$5.3 million), representing the final payment on the principal amount of its convertible senior notes ("Notes") at a total cash cost of $7.4 million (~US$5.5 million), including accrued interest. Following the completion of this repayment, Aurora's remaining debt1 of $47.9 million rela

    Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, today announced the partnership of Aurora Medicine UK Ltd with Script Assist, a cutting-edge medical cannabis prescription platform in the UK.

    Key Takeaways; Cannabis Sector Key Takeaways; Psychedelic Sector Below is a weekly roundup on the cannabis and psychedelic sectors. In this ever-evolving landscape, we explore the major developments and groundbreaking initiatives happening among companies operating in these industries; from advancements in medical research, therapeutic applications to shifts in legal frameworks and current market trends. Top […]

    In this article, we discuss 12 best marijuana stocks to invest in. If you want to skip our discussion on the cannabis market, head over to 5 Best Marijuana Stocks To Invest In. In 2024, the global cannabis market is poised for substantial growth due to emerging legal markets, innovative products, and technological advancements. The […]

    The Canadian cannabis market hasn't been a good place to invest during the past half-decade.